When Silence is Golden in MedTech Reimbursement
Published on: 30/10/2024
In MedTech reimbursement, no news can be good news. Learn how to reduce payer confusion and build clarity into your strategy.
reimbursement executioncoding strategypayer communicationCategory IIICPT CodeFDAValue StoryCoveragePayer EngagementRWEReal-World Evidence
The World After FDA Clearance: From HOORAY! To WAIT, WHAT?
Published on: 20/08/2024
FDA clearance is a milestone—not the finish line. Why reimbursement hurdles follow right after.
FDAPayer ExpectationsMedicarePayment ReadinessCommercial
Relearning English When it Comes to FDA and CMS Jargon
Published on: 04/06/2024
MedTech teams often misunderstand what regulators mean. This article translates FDA and CMS jargon into actionable insights for reimbursement.
FDACMSFood and Drug AdministrationMedicareMedicaidAIExperimentalInvestigational
What Do Payers Mean by “Clinical Utility”?
Published on: 01/06/2024
“Clinical utility” is one of the most misunderstood payer terms. This article explains what U.S. payers expect and how to prepare.
AIArtificial IntelligenceMachine LanguageMLClinical UtilityEvidenceAI/MLInterventionPayersRegulatory ApprovalFDAFood and Drug Administration
